Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Codagenix
3152
Codagenix
Technology
Biotechnology
Designer Viruses ~ Vaccine Development ~ Synthetic Biology ~ Ultra Low Dose Influenza Vaccines ~ Customized Dengue
Suggest edits
Type
B2c
Founded
2011
Raised
$26M
Follow us
Companies in the same industry
PneumaCare
Biolase
Scripps Research
Wakati
Clinipace Worldwide
Merganser Biotech, Inc.
ORRECO
SQZ Biotech
Lab7 Systems
Virtual Incision Corp (VIC)
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
13 Jan
2020
$20,000,000
Venture capital
Topspin Fund
,
Topspin Partners
,
Euclidean Capital
,
+1
Codagenix raises $20 million for a new flu vaccine and other therapies
TechCrunch
12 Oct
2017
$3,000,000
Venture capital
Topspin Partners
12 Jun
2015
$2,000,000
Venture capital (Series A)
Topspin Fund
Added by
With $2M, Codagenix Becomes Accelerate LI’s First VC-Backed Grad
Xconomy
28 Jun
2014
$1,000,000
Grant
